D.b.p. Distribution Titanium Recall: FDA Class I

Why it was recalled

Marketed without an approved NDA/ANDA: undeclared sildenafil and tadalafil.

Product description

Titanium 4000, capsule, 4000 mg, 1 count blister card, 30 blister display boxt, distributed by Titanium 4000 UPC 86077000020

Lot numbers, UPCs & expiration codes

Expiration 12/29/2020

Where it was sold

Nationwide.

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-1292-2019
Classification: Class I
Status: Terminated
Recall initiated: Apr 23, 2019
FDA report date: May 22, 2019
Quantity: unknown
Recall type: Voluntary: Firm initiated
Recalling firm: D.B.P. Distribution

Original FDA data

Every field from FDA enforcement report D-1292-2019, exactly as published.

Show all FDA fields

City: Chatsworth
State: CA
Status: Terminated
Country: United States
Event ID: 82758
Address: 23550 Ehlers Dr
Code information: Expiration 12/29/2020
Postal code: 91311-6310
Report date: May 22, 2019
Product type: Drugs
Recall number: D-1292-2019
Classification: Class I
Recalling firm: D.B.P. Distribution
Product quantity: unknown
Termination date: Mar 7, 2023
Reason for recall: Marketed without an approved NDA/ANDA: undeclared sildenafil and tadalafil.
Voluntary / mandated: Voluntary: Firm initiated
Product description: Titanium 4000, capsule, 4000 mg, 1 count blister card, 30 blister display boxt, distributed by Titanium 4000 UPC 86077000020
Distribution pattern: Nationwide.
Recall initiation date: Apr 23, 2019
Initial firm notification: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date: May 22, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1292-2019, published May 22, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

D.B.P. Distribution Titanium 4000 Recall

Summary